A rapid and systematic review of the effectiveness and cost-effectiveness of the taxanes used in the treatment of advanced breast and ovarian cancer.

Abstract
Health Technology Assessment Volume: 4, Issue: 17, Published in October 2000
Funding Information
  • Health Technology Assessment Programme (99/17/01)

This publication has 0 references indexed in Scilit: